Literature DB >> 29710464

Cistanche deserticola polysaccharides protects PC12 cells against OGD/RP-induced injury.

Yue Liu1, Hui Wang1, Mei Yang1, Ning Liu1, Yuping Zhao1, Xue Qi1, Yang Niu1, Tao Sun1, Yuxiang Li1, Jianqiang Yu2.   

Abstract

Ischemia stroke is a disease with high morbidity and mortality. Cistanche deserticola polysaccharides (CDP) possess a wide range of beneficial effects, including hepatoprotection and immune homeostasis. As far as we know, the protective effect of CDP on neurons injured by oxygen-glucose deprivation/reperfusion (OGD/RP) has not been investigated. In this study, OGD/RP injured a PC12 cell model. Briefly, CDP (0.05, 0.5 and 5??g/ml) was administered before reperfusion. The protective effect of CDP was then evaluated on the basis of cell viability, lactate dehydrogenase (LDH) leakage, [Ca2+]i, mitochondrial membrane potential (MMP)and cell apoptosis, and redox status after reperfusion was evaluated by assaying reactive oxygen species (ROS), catalase (CAT), glutathione peroxidase (GSH-Px) and total antioxidant capacity. Basing on the fact that Parkinson's disease-associated protein DJ-1 participates in endogenous antioxidation and performs neuroprotective effects after ischemia stroke, we investigated the interaction between CDP and DJ-1. DJ-1 expression was detected through ELISA and Western blot analysis, and the translocation of DJ-1 was evaluated through immunofluorescence. Result showed that CDP (0.05, 0.5 and 5??g/ml) attenuated PC12 cell death, preserved MMP and calcium homeostasis; inhibited oxidative stress and decreased cell apoptosis. Moreover, CDP (5??g/ml) markedly stimulated DJ-1 secretion and expression. Overall, the results suggested that CDP exerts neuroprotective effect against OGD/RP-induced injury by inhibiting oxidative stress and regulating the DJ-1 pathway.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cistanche deserticola Polysaccharides; DJ-1; Neuroprotective; Oxidative stress; Oxygen glucose deprivation/reperfusion

Mesh:

Substances:

Year:  2018        PMID: 29710464     DOI: 10.1016/j.biopha.2018.01.114

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

Review 1.  Cistanche Deserticola for Regulation of Bone Metabolism: Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis.

Authors:  Cheng Wang; Feng Li; Yang Li; Hui Feng; Min-Wei Zhao; Peng-Fei Tu; Hua Tian
Journal:  Chin J Integr Med       Date:  2022-08-05       Impact factor: 2.626

2.  MiRNA-34c-5p protects against cerebral ischemia/reperfusion injury: involvement of anti-apoptotic and anti-inflammatory activities.

Authors:  Yaoran Tu; Yong Hu
Journal:  Metab Brain Dis       Date:  2021-04-12       Impact factor: 3.655

3.  MicroRNA-579-3p Exerts Neuroprotective Effects Against Ischemic Stroke via Anti-Inflammation and Anti-Apoptosis.

Authors:  Jiaoying Jia; Yan Cui; Zhigang Tan; Wenjia Ma; Yugang Jiang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-12       Impact factor: 2.570

4.  Effects of the Cistanche tubulosa Aqueous Extract on the Gut Microbiota of Mice with Intestinal Disorders.

Authors:  Xiaowei Bao; Dongwen Bai; Xiaolu Liu; Ying Wang; Lanjun Zeng; Chenye Wei; Weiquan Jin
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-14       Impact factor: 2.629

Review 5.  Mitochondrial MPTP: A Novel Target of Ethnomedicine for Stroke Treatment by Apoptosis Inhibition.

Authors:  Yangxin Li; Jiayi Sun; Ruixia Wu; Jinrong Bai; Ya Hou; Yong Zeng; Yi Zhang; Xiaobo Wang; Zhang Wang; Xianli Meng
Journal:  Front Pharmacol       Date:  2020-03-25       Impact factor: 5.810

6.  Cistanche deserticola polysaccharide induces melanogenesis in melanocytes and reduces oxidative stress via activating NRF2/HO-1 pathway.

Authors:  Yibo Hu; Jinhua Huang; Yixiao Li; Ling Jiang; Yujie Ouyang; Yumeng Li; Lun Yang; Xiaojiao Zhao; Lihua Huang; Hong Xiang; Jing Chen; Qinghai Zeng
Journal:  J Cell Mol Med       Date:  2020-02-25       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.